Hailey Tran
The Sidney Kimmel Cancer Center at Thomas Jefferson University Hospitals is a designated Center of Excellence in cancer care and research. The center provides treatment for various cancers, including leukemia, and has a strong focus on patient care, research, and innovation. With a multidisciplinary team of specialists, the center offers personalized treatment plans and has a well-established transplant program with impressive outcomes. Located in Philadelphia, the center serves the urban population and adjacent communities, aiming to improve the lives of cancer patients and their families.
| Characteristics | Values |
|---|---|
| Hospital Name | Thomas Jefferson University Hospitals |
| Department | Sidney Kimmel Cancer Center |
| Location | Philadelphia and its adjacent communities |
| Specialties | Cancer care and research |
| Types of Cancer | Acute and chronic myelogenous and lymphocytic leukemia, Hodgkin and non-Hodgkin lymphoma, multiple myeloma, bone marrow cancer, melanoma |
| Services | Bone marrow transplants, radiation oncology, pathology, radiology, infusion chairs and beds, exam rooms |
| Patient Care | Seamlessly integrated with research and education, personalized treatment plans, smooth transitions, urgent care program |
| Research Focus | Cancer risk and control, implementation science, cancer health disparities, clinical trials, molecular oncology regulation |
| Faculty | Leading medical oncologists, radiation oncologists, pathologists, radiologists, transplant specialists, Dr. Hoda Badr, Dr. Min Woo Hwang |
| Reputation | Center of Excellence, unique approach to haplo-identical transplants, international recognition |
| Patient Volume | Evaluates more than 2,000 newly diagnosed cancer patients annually, approximately 20,000 outpatient visits in FY2010 |
Explore related products
What You'll Learn
- Thomas Jefferson University Hospitals' Sidney Kimmel Cancer Center is designated as a Center of Excellence in cancer care and research
- The center provides treatment for some of the most challenging cancers, including acute and chronic myelogenous and lymphocytic leukemia
- The Bone Marrow Transplant Program has completed over 1,000 transplants with impressive outcomes and the region's highest one-year patient survival rates
- The center offers seamless patient care, integrating cutting-edge research and education with a multidisciplinary team of specialists
- The Division of Population Science was established to advance research in behavioral, social, and epidemiological science to improve cancer care and reduce its burden
Thomas Jefferson University Hospitals' Sidney Kimmel Cancer Center is designated as a Center of Excellence in cancer care and research
Thomas Jefferson University Hospitals Sidney Kimmel Cancer Center is designated as a Center of Excellence in cancer care and research. The center serves the patient population of urban Philadelphia and its adjacent communities, providing advanced clinical care, innovative transdisciplinary research, dynamic training, and mentorship. It is committed to improving the lives of cancer patients and their families through compassion, innovation, and groundbreaking discoveries.
The Sidney Kimmel Cancer Center (SKCC) is a collaboration between Thomas Jefferson University and Drexel University, leveraging the unique expertise, resources, and capabilities of these two esteemed institutions. The center is dedicated to eradicating the impact of cancer, including disparities and inequities, in the community and beyond. It offers a comprehensive range of services, including cancer risk assessment, implementation science, addressing cancer health disparities, conducting clinical trials, and advancing molecular oncology regulation.
The SKCC is also home to the Division of Population Science, established in 2008 to provide a central focus for institutional research activities related to cancer prevention and control. This division currently consists of three research faculty members who advance applied research in behavioral, social, and epidemiological sciences. They also develop new methods to improve cancer care quality and reduce its burden on diverse populations.
The SKCC is renowned for its multidisciplinary approach to patient care and treatment. Its team includes leading medical oncologists, radiation oncologists, pathologists, radiologists, and transplant specialists. They collaborate to deliver personalized, evidence-based treatment plans for various cancers, including acute and chronic myelogenous and lymphocytic leukemia, Hodgkin and non-Hodgkin lymphoma, and multiple myeloma.
The center also has a strong focus on patient accessibility and satisfaction. It offers extended hours at its Center City site, operates an inpatient oncology unit with 25 beds, and provides outpatient services with over 30 infusion chairs and beds and more than 20 exam rooms. Additionally, the SKCC has established an international reputation for its unique approach to haplo-identical transplants within its transplant program.
Swedish Medical Center: A Top-Tier Hospital Option?
You may want to see also
Explore related products
The center provides treatment for some of the most challenging cancers, including acute and chronic myelogenous and lymphocytic leukemia
The Sidney Kimmel Cancer Center at Thomas Jefferson University Hospitals is a leader in the diagnosis and treatment of hematologic malignancies, including some of the most challenging cancers. The center has been designated as a Center of Excellence in cancer care and research, and its team of medical professionals is dedicated to providing seamless, personalised treatment plans for patients with acute and chronic myelogenous and lymphocytic leukemia, as well as other complex cancers.
The Kimmel Cancer Center brings together a multidisciplinary team, including medical oncologists, radiation oncologists, pathologists, radiologists, and transplant specialists. This collaborative approach ensures that patients receive evidence-based, individualised treatment. The center's focus on cutting-edge research and education further enhances the quality of care provided.
Thomas Jefferson University Hospitals' Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation is composed of experienced physicians with subspecialty oncology expertise in leukemias and related conditions. The division's Bone Marrow Transplant Program has completed over 1,000 transplants, achieving impressive outcomes and the region's highest one-year patient survival rates for 2013 and 2014. Their unique approach to haplo-identical transplants has earned them an international reputation.
The center's commitment to patient care is evident in their efforts to increase availability and accessibility. They offer extended hours and an urgent care program to better serve their patients and reduce the need for emergency room visits. With locations across Philadelphia, including Center City, South Philadelphia, and the Northeast, Thomas Jefferson University Hospitals provide convenient access to comprehensive cancer care.
Overall, the Sidney Kimmel Cancer Center at Thomas Jefferson University Hospitals is well-equipped to handle the treatment of challenging cancers, including acute and chronic myelogenous and lymphocytic leukemia. Their multidisciplinary approach, cutting-edge research, and patient-centric initiatives make them a leading center for leukemia treatment.
PPO Hospital Stays: Understanding Authorization Requirements
You may want to see also
Explore related products
The Bone Marrow Transplant Program has completed over 1,000 transplants with impressive outcomes and the region's highest one-year patient survival rates
Thomas Jefferson University Hospitals' Sidney Kimmel Cancer Center is at the forefront of innovation in the diagnosis and treatment of hematologic malignancies, including acute and chronic myelogenous and lymphocytic leukemia. The Bone Marrow Transplant Program has completed over 1,000 transplants with impressive outcomes, including the region's highest one-year patient survival rates.
The Bone Marrow Transplant Program, led by a team of experienced physicians with subspecialty oncology experience, has established an international reputation for its unique approach to haplo-identical transplants. This program is just one example of how Thomas Jefferson University Hospitals is pushing the boundaries of cancer treatment.
The Sidney Kimmel Cancer Center is a designated Center of Excellence, known for its innovative transdisciplinary research and dynamic training. It serves the urban Philadelphia community and its adjacent areas, offering the most advanced clinical care to its patients. The center is committed to improving the lives of cancer patients and their families through compassion, innovation, and groundbreaking discoveries.
The Bone Marrow Transplant Program's success is a testament to the hospital's dedication to providing the best possible care for its patients. With over 1,000 completed transplants, the program has become a leader in the field, attracting leading medical professionals and offering hope to those facing leukemia. The program's impressive one-year survival rates speak to the skill and expertise of the medical team and the effectiveness of their unique approach.
The hospital's commitment to leukemia treatment extends beyond the Bone Marrow Transplant Program. The Solid Tumor Division, for example, focuses on a range of subspecialty programs, including common and rare solid malignancies. The hospital also offers multidisciplinary breast, GU, and lung clinics, providing comprehensive care for patients with leukemia and other cancers.
Why Doulas Are Essential for Hospital Births
You may want to see also
Explore related products
The center offers seamless patient care, integrating cutting-edge research and education with a multidisciplinary team of specialists
The Sidney Kimmel Cancer Center at Thomas Jefferson University Hospitals is a leader in cancer care and research, designated as a Center of Excellence. The center is committed to eradicating the impact of cancer and advancing cancer treatment, research, and education. It serves the urban Philadelphia community and its surrounding areas, leveraging the expertise and resources of Thomas Jefferson University and Drexel University.
The Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation is a key part of the center, with 12 physicians providing clinical expertise and research opportunities for leukemias, lymphomas, myeloma, and bone marrow transplants. The team has completed over 1,000 bone marrow transplants, achieving the highest one-year patient survival rates in the region for 2013 and 2014. Their unique approach to haplo-identical transplants has garnered international recognition.
The center's commitment to patient care is evident in its facilities and accessibility. The Center City location provides a modern facility with over 30 infusion chairs, more than 20 exam rooms, and 30,000 outpatient visits in 2010. They also offer evening and weekend appointments and plan to launch an urgent care program to better serve their patients. Additionally, the center has a 12-bed transplant unit and a 25-bed oncology unit for inpatient care.
The Sidney Kimmel Cancer Center at Thomas Jefferson University Hospitals is dedicated to providing the highest level of patient care, integrating research and education, and offering seamless, personalized treatment plans through its multidisciplinary team. Their reputation and expertise in leukemia and other hematologic malignancies make them a trusted choice for cancer care.
Sterilization Strategies: Keeping Contaminants at Bay
You may want to see also
Explore related products
The Division of Population Science was established to advance research in behavioral, social, and epidemiological science to improve cancer care and reduce its burden
Thomas Jefferson University Hospitals, specifically the Sidney Kimmel Cancer Center, is designated as a Center of Excellence in cancer care and research. The center treats some of the most challenging and complex cancers, including acute and chronic myelogenous and lymphocytic leukemia. The Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation at Jefferson consists of 12 physicians with subspecialty oncology experience in specific hematologic malignancies and palliative care. They provide clinical expertise and research opportunities for leukemias, lymphomas, myeloma, and bone marrow transplantation related to these conditions. Jefferson's Bone Marrow Transplant Program has completed over 1,000 transplants with impressive outcomes, including the highest one-year patient survival rates in the region for 2013 and 2014.
In 2008, the Department of Medical Oncology and the Kimmel Cancer Center at Thomas Jefferson University established the Division of Population Science to focus on research related to cancer prevention and control. The division aims to advance applied research in behavioral, social, and epidemiological science and develop new methods to improve cancer care and reduce the burden of cancer.
The Division of Population Science's work is essential in understanding the social and behavioral determinants of cancer, which are critical in developing more effective interventions. This transdisciplinary approach integrates the study of the biological nature of cancer with its clinical applications and social and behavioral influences. By understanding these complex interactions, the division strives to reduce cancer's burden on public health and enhance cancer survivors' quality of life.
The division's research activities are wide-ranging and collaborative, including surveillance, epidemiology, health services, behavioral science, and cancer survivorship. They play a central role in providing expertise and evidence on various issues, such as the quality and economic impact of cancer care, statistical methods, communication science, and comparative effectiveness research.
Additionally, the division's efforts align with the broader goals of cancer control science, which aims to reduce the risk, incidence, and deaths from cancer. Through innovative research and leadership, they strive to become a national model for cancer control science, ultimately working towards a world without the burden of cancer.
Training Proof: Hospitals' Employee Education Verification
You may want to see also
Frequently asked questions
The Sidney Kimmel Cancer Center at Thomas Jefferson University Hospitals is designated as a Center of Excellence in cancer care and research. The hospital has established an international reputation for its unique approach to haplo-identical (half-matched) transplants and is building a similar reputation for its leukemia program.
The hospital's Bone Marrow Transplant Program has completed more than 1,000 bone marrow transplants with impressive outcomes, including the region's highest actual one-year patient survival rates for 2013 and 2014. The hospital also provides clinical expertise and research opportunities for leukemias, lymphomas, myeloma, and bone marrow transplantation related to these conditions.
Thomas Jefferson Hospital has a recently constructed facility in Center City with over 30 infusion chairs and beds and more than 20 exam rooms. There is also an inpatient oncology unit with 25 beds and a 12-bed transplant unit. The hospital offers outpatient visits and inpatient care.
